Location: Minnetonka, MN
CIK: 0001683689 · Show all filings
Period: Q1 2021 (← Previous) (Next →)
Filing Date: May 17, 2021
Total Value: $225M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| NEO | NeoGenomics Inc. | 2,203,165 | $106M | 47.2% | $48.23 | $23.81 | +102.5% | COM NEW | 64049M209 |
| — | Horizon Therapeutics Public Limited Company | 546,775 | $50.33M | 22.4% | $92.04 | $67.70 | — | SHS | G46188101 |
| VCEL | Vericel Corporation | 574,080 | $31.89M | 14.2% | $55.55 | $14.84 | +274.4% | COM | 92346J108 |
| IEFA | ISHARES TR | 182,128 | $13.12M | 5.8% | $72.05 | $71.39 | +0.9% | CORE MSCI EAFE | 46432F842 |
| IEMG | ISHARES TR | 196,766 | $12.66M | 5.6% | $64.36 | $65.77 | -2.1% | CORE MSCI EMKT | 46434G103 |
| FIVN | Five9, Inc. | 66,525 | $10.4M | 4.6% | $156.33 | $78.60 | +98.9% | COM | 338307101 |
| IVV | ISHARES TR | 292 | $116K | 0.1% | $397.26 | $332.80 | +19.5% | CORE S&P500 ETF | 464287200 |
| ISTB | ISHARES TR | 2,050 | $105K | 0.0% | $51.22 | $51.57 | -0.5% | CORE 1 5 YR USD | 46432F859 |
| IAGG | ISHARES TR | 783 | $43,000 | 0.0% | $54.92 | $55.67 | -1.5% | CORE INTL AGGR | 46435G672 |
| IMTB | ISHARES TR | 764 | $39,000 | 0.0% | $51.05 | $52.45 | -2.8% | CR 5 10 YR ETF | 46435G417 |
| IJH | ISHARES TR | 147 | $38,000 | 0.0% | $258.50 * | $37.39 | +39.2% | CORE S&P MCP ETF | 464287507 |
| IJR | ISHARES TR | 207 | $22,000 | 0.0% | $106.28 * | $71.67 | +51.4% | CORE S&P SCP ETF | 464287804 |